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Abstract: Pulsed field gradient (PFG) NMR is a versatile method for studying molecular 
transport and exchange in solution.  Provided that certain conditions are satisfied, Stejskal-Tanner 
diffusion plots can be used to distinguish between chemical species even in the absence of chemical 
shift or T1 resolution. This can be used to a great advantage in colloidal drug delivery systems 
containing two drug populations, free and bound, which can often be distinguished only from their 
diffusion coefficient. We discuss the factors affecting the resolution of the two pools in Stejskal-
Tanner plots, as well as the effects of chemical exchange between them. We also present two 
examples of this analysis: surfactant-based micelles containing the general anesthetic propofol and 
lipid/water liquid crystalline mesophase-based vehicles (cubosomes).   
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Introduction 
 
Purpose 
Our aim is to describe how a drug’s incorporation into and release from colloidal carriers can be 
characterised using NMR spectroscopy. While the characterization invariably involves a range of 
physical and chemical techniques, pulsed field gradient (PFG) NMR measurement of diffusion has 
proven of particular value in our own hands (and that of many other groups). The basic idea for its 
use is that a low-molecular weight drug will have a relatively high diffusion coefficient if it is in 
free solution, but a low one when it is associated with a colloidal carrier. The binding affinity of the 
drug can be deduced from both the apparent weighted-average diffusion coefficient (Dave) and from 
biexponential signal attenuation curves. All this is done in a way that does not perturb the chemical 
equilibrium in the sample.  
 
Motivation  
Scientists and the pharmaceutical industry continually strive to develop an ever-increasing range of 
therapeutic drugs. Modern biochemistry, chemistry and physics have greatly contributed to the 
success of these ventures through providing an understanding of the mechanisms of drug action and 
through rational drug design (1, 2). However, the development of new drugs is only one component 
on which the success of these therapies depends. Another key element is an efficient means of 
delivering the drug and ensuring its bioavailability. Some of the reasons why drugs that initially 
showed promise on in vitro testing turned out to be failures in vivo are as follows (3): (1) low 
aqueous solubility; (2) low rate of absorption; (3) rapid metabolism; (4) inappropriate timescale of 
the release of the drug;  (5) distribution to tissues other than the intended target ones; (6) tissue-
specific or general toxicity; and (7) unpredictable influence of food on orally administered drugs. It 
is generally accepted that one of the ways of dealing with these problems is to use mesoscale 
supramolecular particles, or “carrier vehicles”, to deliver the drug (4, 5). These vehicles encapsulate 
the drug and, ideally, convey it to its intended destination. Typically, drug delivery vehicles are 
composed of self-assembling or cross-linked large amphiphilic molecules, such as surfactants or 
lipids. The best-known vehicles are liposomes (e.g. phospholipid/cholesterol vesicles); these were 
discovered in the 1960s (6) and have since been used with a wide variety of drugs. Liposomes are 
closed structures that are bounded by one or several concentric bilayer shells (lamellae). The shells 
are composed of hydrated phospholipid (and cholesterol). Liposomes are capable of incorporating 
both hydrophilic and hydrophobic drugs (in the internal aqueous compartment and in the lipid 
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bilayer, respectively). The properties of liposomes (including their size distribution, average number 
of lamellae, electrical charge, and surface potential) can often be altered in a controlled way. In 
many cases, the specificity of liposomes with respect to a target tissue can be enhanced by attaching 
receptor-specific antibodies to their surface; these are called immunoliposomes (7). These and other 
properties made liposomes versatile  and for a long time the only well studied drug delivery 
vehicles.  
 
Delivery vehicles 
Since the discovery of liposomes drug delivery technology has progressed significantly. Several 
classes of vehicles are now available, including: (1) surfactant micelles (8, 9); (2) macro- and 
microemulsions (10, 11); (3) amphiphilic lipid/water liquid crystalline phases (4); and (4) 
dispersions of the latter in water (12, 13). A separate class of applications is the delivery of MRI 
contrast agents (7, 14-16). Despite the diversity, the fundamental expectations of all drug delivery 
vehicles are essentially the same (3, 17): (1) facile large-capacity solubilization of the drug; (2) its 
controlled and sustained release; (3) the possibility of organ or tissue targeting; (4) biochemical 
protection of the drug leading to increased drug stability and lower toxicity; (5) the absence of 
toxicity of vehicular material or its accumulation in organs; (6) the absence of adverse interactions 
with biological surroundings, e.g., reticuloendothelial and immune systems and plasma proteins 
(18, 19); (7) suitability for a wide range of drugs; (8) long circulation lifetime; (9) biodegradability; 
(10) easy, reproducible, and low-cost production; and (11) long storage lifetime. In other words, 
evaluating the practical potential of a given drug-delivery system involves a multitude of diverse 
considerations relating to both the drug and the vehicle, as well as the in vivo environment. We 
describe next how NMR can be used in this evaluation process. 
 
Methods of study  
NMR spectroscopy can be useful in evaluating any of the aspects listed in the previous paragraph. 
The scientific literature offers a wealth of information on this topic, so its in-depth review is neither 
justified nor feasible here. Several recent reviews and specific examples are given in the following 
articles (1, 2, 8, 11, 20-23). The scope of this article will be limited to the invariable first step in the 
vehicle evaluation process - in vitro characterization of the distribution of the drug between the 
solution and the vehicles, as well as its exchange between its “free” and “bound” state. Thus we 
consider only one aspect of the big picture of drug delivery systems and treat it from a physico-
chemical rather than a pharmacological perspective.  
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NMR and binding 
NMR spectroscopy is now well established as a means of investigating chemical exchange in 
solution (24, 25) or transport across membranes in vesicles or cells (26, 27). Several techniques are 
available for these purposes, including PFG NMR diffusion measurements (24, 28); measurements 
of the relaxation times T1, T1r, and T2 (29); and magnetization transfer experiments (30, 31). 
Because these techniques exploit the dynamics of a molecular system on different time scales, the 
results that they yield are often complementary. Again, an all-encompassing review of these 
techniques is precluded by space considerations.  
 
While relaxation and magnetization transfer experiments are very informative for studying 
molecular association, we have confined this article to an in-depth coverage of PFG NMR diffusion 
measurements (26). The diffusion coefficient of a molecule is directly related to its size and 
therefore can be used to distinguish between free and vehicle-bound drug. Because the 
interpretation of results is relatively straightforward, diffusion experiments provide an attractive and 
easy method for verifying the presence of drug-vehicle association; and in a well defined window of 
conditions these measurements can yield estimates of the rate constants for drug exchange between 
the vehicle and free solution.  
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The model 
 
We consider a simple two-site exchange of a drug between its free and bound state:  
 
 A B
k
k
+
-
  [1] 
 
where A and B denote the free and the bound drug populations, and k+ and k- are the forward and 
reverse exchange rate constants, respectively. We assume that the vehicles are monodisperse. The 
overall system is illustrated in Fig. 1. The term “free” in the present context implies that the drug is 
not bound to the delivery vehicle, but it may still be associated with other molecules or cellular 
components; in the latter cases it may be necessary to extend the model for a more complete 
description of the system. We also assume that the system is always in chemical equilibrium, and 
the equilibrium constant is given by Keq = [B]/[A] = k+/k- . The equilibrium allows us to treat the 
forward reaction in [1] as a pseudo-first order one, in which the concentration of vehicles is 
incorporated into k+.  
 
Because the diffusion coefficients measured from different NMR peaks of the same species should 
be the same, we consider only one peak for each of the free and the bound states. Also, we assume 
that the peaks of A and B are superimposed in the spectrum so that only the total signal intensity, S, 
can be observed:   
 
 A BS S S= +  [2] 
 
The individual signal intensities of A and B, SA and SB, are not directly available from the NMR 
spectrum. We denote the signal intensities following a single 90o pulse as SA0 and SB0, and the mole 
fractions of the two forms as xA and xB, respectively. By definition, xA + xB = 1. It is easily seen that 
xA/xB = SA0/SB0, and due to chemical equilibrium  
 
 A0 B0S k S k+ -=  [3] 
 
Next, we assume that the free and the bound drug are characterized by intrinsic diffusion 
coefficients and relaxation rate constants DA, R1A, R2A and DB, R1B, R2B, respectively. For protons in 
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small molecules, the relaxation in the free molecule is usually slower than in the bound form, hence 
R1A < R1B. By definition, DA > DB.  
 8
PFG NMR diffusion measurements 
 
In this Section, we derive the mathematical equations necessary for the analysis of diffusion 
experiments. The key results are contained in Eqs. [12], [14], and [15] below. We recommend that 
the student numerically plots the Stejskal-Tanner curves for a few sample systems of his or her 
choice. Analytical verification of the solutions can entail some effort. Should a mathematically 
inclined student decide to do that, a symbolic mathematics software (such as Mathematica, 
Wolfram Research Inc., Champaign, IL) would be useful.   
 
The measurement of diffusion by NMR uses RF pulse sequences coupled with pulsed magnetic 
field gradients (PFG); these sequences range from simple ones such as the two-pulse PFG spin-echo 
experiment (PGSE) to sophisticated many-pulse sequences designed to compensate for flow or 
convection or to reduce the effects of eddy currents (24, 32-35). All of these experiments share the 
same basic feature that the NMR signal at a given value of magnetic field gradient strength, from a 
species possessing a diffusion coefficient D, has the functional form  
 
 ( ) (0) D b qS q S e- ( )=  [4] 
 
where b(q) is the independent variable of the so-called Stejskal-Tanner plot (35).  In many 
circumstances, it can be represented as the product of an effective diffusion time and the maximum 
value of q within the pulse sequence; however, in the general case it is defined as  
 
 2
0
( )
seqt
b q t dt¢ ¢= ò  [5] 
 
where tseq is the duration of the pulse sequence (from the first RF excitation pulse to the beginning 
of signal acquisition). The so-called spatial wave vector q is the tightness of the magnetization 
grating wound by pulsed field gradients:  
 
 
0
( ) *( )
t
t t dt
¢
¢ ¢¢ ¢¢= gòq g  [6] 
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(The effective gradient strength g* equals the nominal gradient strength g multiplied by a factor of 
1, -1, or 0, depending on whether at any given time the magnetization helix is being wound, 
unwound, or unaffected by PFGs.)  
 
To understand how chemical exchange between A and B affects the observed signal, we will 
consider the basic spin echo (PGSE) experiment shown in Fig. 2 (24, 36). We chose this experiment 
because of the simplicity of relaxation treatment. At the same time, stimulated echo (STE) 
experiment may be more appropriate if T1 > T2 and D > T2; analysis similar to the present one can 
be applied to STE. In PGSE, the first field gradient pulse winds a helical magnetization grating 
along the direction of the gradient, with a wavevector q proportional to g and d, and initial 
amplitude M0:  
 
 ( )i0( , 0)M t M e
- × +f
+ = =
q rr  [7] 
 
where vector quantities are shown in bold. The phase f is inconsequential for our purposes. After 
the first gradient pulse, the grating evolves for the time D. During this evolution, the magnitude of q 
is conserved but the amplitude of the grating exponentially decays with time. The 180o RF pulse 
inverts the direction of precession of magnetization isochromats part way during D, while the 
second magnetic field gradient pulse brings them back into alignment, giving rise to the spin echo.  
 
If the two field gradient pulses are rectangular, then the Stejskal-Tanner coordinate of the PGSE 
experiment is b = q2(D - d/3), and for a single D = DA  the echo amplitude attenuates with q as  
 
 ( )
2
A / 3
A A( ) (0)
D qS q S e- D-d=  [8] 
 
The zero-q amplitude SA(0) incorporates the effects of relaxation and RF pulses; its maximum 
possible value is SA0, which in turn is proportional to MA0. If the chemical species is present in two 
different non-exchanging forms, then the signal is the sum of two terms of the type in Eq. [8]:  
 
 ( ) ( )
2 2
A B/ 3 /3
A B A B(0) (0)
D q D qS S S S e S e- D-d - D-d= + = +  [9] 
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The biexponential Stejskal-Tanner plot arising from Eq. [9] is schematically represented in Fig. 3. 
The significance of the grey areas in that Figure will be explained later in the article. The plot 
contains two asymptotic regions, initial and terminal; their intercepts and slopes are ri, si, and rt, st, 
respectively.  Experimentally, the values of DA and DB can be determined from the plot of Fig. 3 by 
applying the exponential peeling procedure (37): (1) DB = -st; (2) xA = exp(rt - ri); (3) xA = 1 - xB; 
(4) DA = -(si + xB DB)/xA.  
 
Chemical exchange and diffusion  
The effect of chemical exchange on signal attenuation in the PGSE experiment can best be 
understood by considering the system shown in Eq. [1] and supposing that the gradient pulses are 
instantaneous. To help in the analysis we define the effective diffusion time td as   
 
 d / 3t =D-d  [10] 
 
In the case of instantaneous gradient pulses, td = D. Suppose that after the first gradient pulse the 
magnetization gratings of A and B have a wave vector q and amplitudes mA+ and mB+, respectively. 
If there is no relaxation and the precession frequencies of A and B are equal, the magnitude of their 
spin-echo signals at the end of the experiment can be obtained from the following coupled 
equations:  
 
 
2
A AA
2
B Bd B
S Sq D k kd
S Sdt k q D k
+ -
+ -
æ ö- -æ ö æ ö
= ç ÷ç ÷ ç ÷- -è ø è øè ø
 [11] 
 
This system is solved for the time td to yield the expression for the combined spin-echo signal of A 
and B:  
 
 
( ) ( ) ( ) ( ) ( )
( ) ( ) ( ) ( ) ( )
d
d
BA
BA
d A d B d
2 2
A B
A
2 2
A B
B
2
2
2
2
( , ) ( , ) ( , )
(0)
2
(0)
2
D D
D D
q
q
t k k
t k k
S q t S q t S q t
k k k k D D q k k
S e
k
k k k k D D q k k
S e
k
æ öç ÷+ - + - + - è ø
-
æ öç ÷+ - + - + - è ø
-
+
+
-+
-+
- W
- W
+ + +
+ + -
= + =
+ + - - - + W
-
W
+ + - - + + W
+
W
 [12] 
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where  
 
 ( )22 A B( ) 4k k q D D k k+ - + -W = - + - +  [13] 
 
The solution in Eq. [12] uses the chemical equilibrium condition given by Eq. [3], as well as the 
assumption that the RF pulses are perfect 90o and 180o pulses. Its implicit limitations are that: (1) 
relaxation has been neglected; and (2) the solution is exact only if the gradient pulses are delta 
functions; otherwise it is approximate.  
 
Equation [12] is valid for the case of non-exchanging as well as chemically exchanging populations. 
For example, for a non-exchanging two-site system all occurences of the ratio k+/k- must be 
replaced with SB0/SA0, and linear and higher degree terms in k+ or k- are set to zero. The solution 
then simplifies to Eq. [9].  
 
To gain a sense of the behaviour of Eq. [12] as a function of the various parameters, it is useful to 
consider its limiting behaviour when q ® 0 or q ® ¥:  
 
(1) q ® 0: In this limit, both SA and SB are close to SA(0) and SB(0), respectively. The observed D is 
the average of DA and DB, which can be verified by expanding Eq. [12] to the first order in b near b 
= 0. The initial slope of the Stejskal-Tanner plot (ln S vs b) becomes the negative weighted average 
of the two diffusion coefficients, -xA DA - xB DB. The respective y-intercept is ln[SA(0) + SB(0)].  
(2) q ® ¥: In this limit, only SB survives. SA attenuates more rapidly than SB when b is increased, 
and eventually becomes negligible to any desired order compared to SB. Therefore, the slope for 
large values of b is exactly the negative of the slow diffusion coefficient, DB. This result is 
confirmed by expanding the logarithm of Eq. [12] with respect to the smaller of the two 
exponentials, differentiating the result with respect to q2, and finding the limit of the derivative as q 
® ¥. The y-intercept of the respective asymptote is given by  
 
 B( ) B dln ln (0)appS S k t-= -  [14] 
 
Hence, the application of the exponential peeling procedure (37) to a Stejskal-Tanner plot of a 
chemically exchanging system (Eq. [1]) ideally produces the expected value of the “slow” diffusion 
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coefficient but it underestimates xB by a factor of exp(-k- td), i.e., ln xB(app) = ln xB - k- td. In 
practice, vehicle polydispersity combined with aquisition noise can render the measured slow 
diffusion coefficient meaningless while yielding the amplitude of the bound drug population that 
follows Eq. [14]. Hence, when the value of DB is required, it should be measured from the signal of 
the vehicle rather than the bound drug; this will become apparent from the example discussed in the 
last section.  
 
Limitations imposed by parameter values  
The asymptotes relating to q ® 0 and q ® ¥ intersect at a value of b that we shall call the critical 
value. Using the slopes and the intercepts of the two asymptotes, obtained above, it can be easily 
found that they intersect at  
 
 ( )
d
A B
1
ln 1
1crit
k t
Kb K
D D
-
æ ö+ +ç ÷
è ø= +
-
 [15] 
 
where, as before, K = k+/k- if the two populations are in exchange and K = SB0/SA0 if there is no 
exchange.  
 
Figure 3 illustrates the significance of bcrit; it separates the low-q part of the Stejskal-Tanner plot 
from the high-q part. Thus, when b =  bcrit, we are dealing with the low-q regime discussed avove. 
Both SA and SB contribute to S in this regime, and the slope of the Stejskal-Tanner plot is equal to 
the negative of the average diffusion coefficient. When b ?  bcrit, we are dealing with the high-q 
regime. In this regime, SA is effectively attenuated out. The slope of the Stejskal-Tanner plot in this 
case is ideally equal to the negative slow diffusion coefficient, -DB, but can be distorted by 
polydispersity or noise, as discussed above.  
 
It is useful to consider domains of the parameter values that allow resolution of the diffusion 
coefficients and population sizes of A and B from a Stejskal-Tanner plot. Figure 3 shows several 
regions of the plot that are experimentally inaccessible; these are indicated in grey shading. The 
significance of these regions is as follows:  
A: the shaded values of b lie outside the experimentally accessible range because the required g is 
greater than that available on a given hardware. Hence the part of the Stejskal-Tanner plot lying 
within this region will not be able to be observed.  
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B: the shaded values of b lie outside the experimentally accessible range because the required td is 
shorter than the time taken for the gradient coil current to stabilize after it is turned off.  
C: the noise level of the measured signal is also shaded in grey. If the signal intensity at the critical 
point, bcrit, lies in this region, the terminal asymptote of the Stejskal-Tanner plot cannot be 
unambiguously defined and the plot appears to be mono-exponential.  
D: this is the flexibility region of the least-squares fit, i.e., the area containing all possible fitted 
lines within the confidence region of the parameter space. This area of the plot is accessible to the 
experimenter. However, if the critical point lies within the shaded region, the two asymptotes will 
not be separable (in the same sense that strongly overlapping Gaussian distributions are not 
separable). This will probably be the case if DA and DB differ by less than a factor of 3 or less.  
 
For the populations A and B to be resolved in a real PGSE experiment, the critical point must lie 
outside the grey areas of Fig. 3. Therefore, the resolution of the two components is limited by 
physicochemical (SA0/SB0 and DA/DB) as well as hardware factors (the maximum accessible g, the 
shortest possible td, and the level of noise). When xB is small, the resolution of the component B is 
limited by the region C. If the terminal asymptote is confined to that region, the component B will 
be unobservable.  
 
Another important observation from Fig. 3 and Eq. [15] is that the resolution of A and B in PGSE 
experiments can be modulated by the choice of td. This is a degree of freedom not present in the 
one-dimensional NMR spectrum or an inversion recovery experiment where the fast and slow 
regimes are determined exclusively by the balance between the intrinsic parameters of the 
chemically exchanging system. On the chemical-shift scale, the fast-exchange and the slow-
exchange situations are given by |k+ - k-| ?  2p Dn and k+ + k- =  2p Dn, respectively (where Dn is 
the frequency difference between the two signals) (38). In the inversion-recovery experiment with 
unresolved chemical shifts, the exchange rate on the T1 time scale is fast if  
 
 1B 1Ak k R R- +- -?  [16] 
 
and slow if  
 
 1B 1Ak k R R+ -+ -=  [17] 
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In the PGSE experiment the time scale of chemical exchange between A and B depends on the 
choice of D, while the attenuation of both SA and SB depends on both D and g. The presence of an 
additional dimension in the experimental parameter space thus allows the modulation of the time 
scale of chemical exchange relative to the time scale of the diffusion experiment, shifting it from 
slow to intermediate or from intermediate to fast; this is not possible with respect to chemical shift 
or relaxation time scales. In general, all three time scales can be distinct, which can be exploited to 
the experimenter’s advantage if the exchange is fast on some time scales but not on others.  
 
Estimating the population size of B  
Now consider how the relative population size of B can be determined from a PGSE experiment. 
The exponential peeling procedure applied to a Stejskal-Tanner plot from an exchanging system 
produces an underestimate of xB (see Eq. [14]). However, we can still determine its true value by 
exploiting the linear dependence of the apparent ln xB on td. All that is required is to measure xB(app) 
in several PGSE experiments with different values of the diffusion interval. The plot of ln xB(app) vs 
td follows a straight line, and linear regression yields the value of ln xB (y-intercept) and k- (the 
negative slope of the regression line).  
 
Effects of relaxation  
So far, we have either neglected relaxation or assumed that the relaxation rates of A and B are 
equal. In the absence of exchange, SA and SB will be attenuated by relaxation in the course of a 
PGSE experiment (Fig. 2) by the factors exp(-2DR2A) and exp(-2DR2B), respectively (39). The 
simplest way to incorporate relaxation in Eq. [11] is to again employ the short-gradient pulse 
approximation. If d ® 0, then td ® D, and Eq. [11] takes the form  
 
 
2
A AA 2A
2
B Bd B 2B
2
2
S Sq D k R kd
S Sdt k q D k R
+ -
+ -
æ ö- - -æ ö æ ö
= ç ÷ç ÷ ç ÷- - -è ø è øè ø
 [18] 
 
The solution can be obtained simply by replacing q2Di in Eqs. [12] and [13] with q2Di + 2R2i. This 
substitution provides insight into how relaxation affects the estimates of the individual amplitudes 
and diffusion coefficients obtained from exponential peeling. Using the relationship q2 = b/td, we 
find that in the presence of relaxation relaxation the two asymptotes of the Stejskal-Tanner plot 
have the form:  
 
 15
 
( ) ( )
( )
d A 2A B 2B A A B B
0
B d 2B B
0
( )
initial : ln 2
( )
terminal : ln ln 2
S b
t x R x R b x D x D
S
S b
x t R b D
S
= - + - +
= - -
 [19] 
  
Equation [19] demonstrates that correcting the apparent exponential-peeling values of xA and xB by 
multiplying them by exp(2tdR2A) and exp(2tdR2B), respectively, is not strictly correct (although our 
experience shows that it produces numerically close results). Instead, the rigorous relaxation 
correction is as follows: (1) correct xB by multiplying the result of exponential peeling by 
exp(2tdR2B); (2) correct the initial net signal by multiplying it by exp(2tdR2ave), where R2ave = xA R2A 
+ xB R2B; (3) calculate xA º 1 - xB; and (4) determine the values of the individual diffusion 
coefficients by using conventional exponential peeling with uncorrected slopes and corrected xA and 
xB.  
 
This correction procedure has an effect on the estimated values only if the two relaxation rate 
constants are different. There are also two limitations on its efficacy: (1) like the solution in Eq. 
[12], it is strictly valid only if the gradient pulses are short; (2) it is not necessarily meaningful in 
the presence of chemical exchange: unless the condition in Eq. [17] is satisfied, R2A and R2B will be 
mixed and lose their individual meaning. Therefore, the relaxation correction should be applied 
only if the gradient pulses are short compared to D, and the exchange is known to be slow. If that is 
not the case, relaxation-uncorrected data must be extrapolated to td = 0, as described above. The 
extrapolation will then produce the correct ln xB, but the slope of the regression line will in general 
contain contributions from k- as well as from the difference between the two relaxation rates.  
 
The above analysis enables the interpretation of the results of PFG NMR diffusion measurements 
on a two-site system (either chemically exchanging or static) where the two NMR signals are 
superimposed and only their sum is acquired. This situation is common in colloidal drug delivery 
systems. In the next two sections, we apply the theory to two examples of drug delivery systems.  
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Micellar solutions 
 
The idea of using micelles as drug delivery vehicles probably originated in the late 1980s (40). Also 
around that time technological advances enabled NMR PFG units to become more reliable and 
affordable. As a result, PFG NMR diffusion methods became widely used in colloid science in 
general (41-44) and colloidal drug delivery in particular (9, 10, 45). In this section, we present as an 
example how PFG NMR is used to study propofol solubilized in a micellar solution of Solutol 
HS15 (8).  
 
Propofol 
Propofol (2,6-diisopropylphenol) is a commonly used general anesthetic. It is administered 
intravenously as a lecithin-stabilized emulsion (commercially available as DiprivanÒ) (46). 
However, this form of administration has at least two disadvantages: (1) the presence of residual 
free propofol in the aqueous phase is thought to lead to pain on intravenous injection (47); and (2) 
the emulsion tends to support bacterial growth (48). Therefore, a search has been made for a robust 
delivery vehicle that overcomes these limitations (49, 50).  
 
Solutol HS15  
A number of nonionic surfactants containing poly(ethylene oxide) (PEO) blocks appear promising 
in this regard (19, 40, 51, 52). Solutol HS15 is a PEO-containing nonionic surfactant which 
possesses several clinically favorable properties as well as low toxicity, making it potentially useful 
for drug delivery (19, 53). Commercially available Solutol HS 15 is a mixture of approximately 
equal amounts (by weight) of poly(ethylene glycol)(15) 12-hydroxystearate (PEO-HS ester, MW ~ 
960) and free poly(ethylene oxide). The structures of the two components, as well as a 1H NMR 
spectrum of a propofol-free 9.15% (w/v) solution in D2O-saline, are shown in Fig. 4. The largest 
proton NMR peak (~3.7 ppm) corresponds to the ethylene oxide groups of both free PEO and 
micellar PEO-HS ester. Its line is inhomogeneously broadened due to the presence of the two PEO 
populations. However, their individual signals cannot be reliably resolved. Therefore, the diffusion 
attenuation of the PEO peak is governed by two separate diffusion coefficients, D of free PEO and 
D of PEO-HS ester micelles. This leads to a biexponential Stejskal-Tanner plot. A typical example 
is shown in Figure 5.  
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Assuming either long or equal T2 values for the two macromolecular components, the ratio of free-
PEO : micellar-PEO is 63:37 (w/w), which is consistent with the ratio known from chromatographic 
analysis. The presence of rapidly-diffusing free PEO blocks in the solution has implications for the 
analysis of diffusion experiments on drug-loaded Solutol HS15 systems.  
 
Propofol is only slightly soluble in water [~150 mg L-1 (54) while for comparison  the solubility of 
benzene in water is 1.9 g L-1  (55)]. However, propofol is soluble in a 10% (v/v) solution of Solutol 
HS15 to a concentration of at least 1% (w/v). Chemical shift values of PEO-HS ester protons 
indicate the uptake of propofol by the surfactant micelles; small fractions of propofol are also in 
free aqueous solution and associated with the free PEO blocks (8, 56).  
 
The state of association of propofol is revealed by the observed tracer diffusion coefficient values of 
propofol and components of Solutol HS15. In a 9.15% (w/v) propofol-free solution of Solutol 
HS15, the diffusion coefficients of PEO-HS micelles and free PEO blocks are 1.9 ´ 10-11 and  1.7 ´ 
10-10 m2 s-1, respectively (the data of Fig. 5). In a system composed of 1% propofol/10% Solutol 
HS15/D2O-saline, the observed values are 1.44 ´ 10-11, 1.27 ´ 10-11, and 1.39 ´ 10-10 m2 s-1 for 
propofol, PEO-HS micelles, and free PEO blocks, respectively (8). Except for the PEO signal, all 
Stejskal-Tanner plots for these solutions are monoexponential.  
 
Two points are worth emphasizing: (1) the diffusion coefficients of both the micelles and the free 
PEO are smaller in the propofol-containing solution, by factors of 1.5 and 1.2, respectively. The 
factor of 1.2 decrease in the value of D of the free PEO can be ascribed to the increased overall 
viscosity of the solution (10% vs 9.15% Solutol HS15; the viscosity strongly depends on the 
surfactant’s concentration). The 1.5-fold decrease of the micellar D is due, in addition to the 
increased viscosity, to the swelling of the micelles upon the addition of propofol. (2) The observed 
D of propofol is 13% greater than the micellar D. The results for other surfactants reveal that this is 
a consistent phenomenon caused by the presence of extramicellar propofol in solution (8). Given 
that there are experimentally observed NOEs between propofol and PEO protons, the extra-micellar 
propofol can be deduced to be associated with the free PEO blocks. The observed D of propofol is 
then the weighted average of micellar and free-PEO D’s. The latter implies that 1% of the all the 
propofol is associated with the free PEO.  
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Finally, this example illustrates the fact that, when the rapidly-diffusing (free-drug) population is 
also the minor one, it is almost impossible to resolve its relative fraction from the initial asymptote 
in a Stejskal-Tanner plot. If there were no exchange between the two populations of propofol, the 
value of bcrit would have been  
 
 ( ) 910 11
1
ln 1
991 99 8.0 10
1.39 10 1.27 10crit
b - -
æ ö+ç ÷
è ø= + = ×
× - ×
 [20] 
 
This bcrit is certainly within an experimentally accessible range. However, because the fraction of 
the fast population is only 1%, the critical point lies within the flexibility region of the fit (area D, 
Fig. 3), making the initial and the terminal asymptotes indistinguishable. The effect of chemical 
exchange between sites is to push the critical point to the right. Even if the exchange is not 
sufficiently fast to push it past the largest experimentally accessible value of b, it would still push 
the point towards lower overall signal amplitudes and greater relative noise, resulting in an even 
smaller likelihood of distinguishing the two asymptotes. Therefore, in this case we are restricted to 
estimating the population fraction and D value of the rapidly diffusing component from the value of 
the average D of propofol and its comparison to those of micelles and free PEO.  
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Cubosome and vesicle dispersions  
 
General 
Lipid/water systems exhibit a great deal of phase polymorphism (57, 58). Water dispersions of a 
given lipid can contain different types of particles, depending on the exact composition as well as 
physical and chemical conditions. A good example of this behaviour is exhibited by monoolein (a 
mixture of monooleic esters of glycerol; 1-monoolein is shown in Fig. 6). Like many lipids, it forms 
vesicles; these are spherical particles that are structurally analogous to unilamellar liposomes 
described in the Introduction. In a certain window of composition, monoolein dispersions also form 
so-called cubosomes (13). These dispersed submicron particles are composed of a lipid bilayer 
contorted into a cubic lattice of Im3m symmetry (Fig. 6). The aqueous channel system within 
cubosome particles is bicontinuous; i.e., it consists of two congruent non-intersecting subsystems. 
The particles are stabilized by a nonionic surfactant. The concentration of surfactant relative to the 
lipid has to be optimized with respect to the following two competing factors: (1) low surfactant 
concentration leads to cubosome flocculation; (2) high surfactant concentration promotes the 
formation of lipid vesicles. For monoolein dispersions stabilized by Poloxamer 407 (Pluronic 127), 
the minimum surfactant:lipid ratio required for particle stability is ~7% (w/w). Dispersions with 
7-10% (w/w) relative surfactant concentration contain mostly cubosomes (>90% of the total lipid); 
higher concentration of surfactant results in an increasingly greater proportion of vesicles.  
 
Drug delivery 
As pointed out in the Introduction, phospholipid vesicles (liposomes) were amongst the first 
discovered lipidic drug delivery vehicles. Cubosomes and non-phospholipid vesicles have recently 
also become a centre of intense interest due to their drug delivery potential (12, 59). Despite the 
significant amount of research performed, many questions remain unanswered. Among these are: 
(1) what is the percentage of cubosome volume available to a hydrophilic solute; and (2) what is the 
rate of molecular exchange between intra-vehicular space and the bulk aqueous phase?  The former 
value can be estimated from the periodic lattice constant and the molecular volume of the lipid (57). 
The latter has been estimated to be “immediate” from the timescale of appearance of Eu3+-induced 
13C paramagnetic shift (60). Until recently a direct measurement of either quantity appeared to be 
lacking, so we consider this next.  
 
Cubosome and vesicle volume 
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The relative intra-vehicular aqueous volume in lipid dispersions prepared in saline solution can be 
measured from the diffusion characteristics of 23Na+ (17). In general, there are three pools of Na+ in 
these systems: intravesicular, intracubosomal, and the bulk solution. The latter two are in a rapid 
(subsecond) chemical exchange. The intravesicular population is non-exchanging on the time scale 
of a diffusion measurement. The intravesicular pool can be distinguished from the other two with 
the use of a chemical shift reagent, such as Dy3+ tripolyphosphate complex (DyPPP2-) (61, 62). 
However, the chemical shifts of intracubosomal and bulk Na+ are indistinguishable because 
cubosome channels are easily accessible to shift reagent ions (60). Despite this disadvantage, the 
population size of intracubosomal Na+ can be estimated from biexponential Stejskal-Tanner 
diffusion attenuation plots of the combined bulk and intracubosomal peak. Also, when the fraction 
of intravesicular population is small, it can be neglected and an estimate of the size of the 
intracubosomal population can be obtained without a chemical shift reagent. A representative 
Stejskal-Tanner plot from a cubosome dispersion with a 10% (w/v) lipid content and no shift 
reagent is shown in Fig. 7. It clearly shows at least two diffusion coefficients with the values of 9.04 
´ 10-10 and 2.65 ´ 10-12 m2 s-1 (obtained from exponential peeling). These values are consistent 
with the presence of two Na+ populations, one in the free solution and one confined to colloidal 
vehicles on the time scale of the PGSE experiment. For comparison, the room-temperature D of Na+ 
in the D2O-saline is 1.0 ´ 10-9 m2 s-1, and independently measured D of cubosomes and vesicles 
were 2.0 ´ 10-12 and 6.5 ´ 10-11 m2 s-1, respectively. The apparent relative sizes of the two 
populations are 97.9% (“fast”) and 2.1% (“slow”). The bcrit separating the two parts of the plot has 
the value of 4.36 ´ 109 s m-2.  
 
Because chemical exchange of Na+ between cubosomes and the bulk solution affects the measured 
xA and xB, the value of 2.1% underestimates the size of the intra-vehicular population. The true 
value can be determined by making the measurement at several td values and extrapolating ln xB(app) 
to td = 0, as described in the section “PFG NMR diffusion measurements” and shown in Fig. 8. The 
resulting intra-vehicular population of Na+, xB, is 0.0374 ± 0.001.  
 
Three points should be noted regarding the interpretation of this result.  The extrapolated xB is 
invariant with respect to relaxation correction, and therefore the value of 0.0374 stands regardless of 
whether the individual R2’s of the two populations are the same or not. We assume that Na+ is 
uniformly distributed and samples the bulk solution and intra-vehicular volume with equal 
probability. Finally, the plots in Figs. 7 and 8 were obtained without a Na+ shift reagent, meaning 
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that intravesicular population contributes to the measured xB. Intravesicular and intracubosomal 
pools of Na+ are not resolved in diffusion plots in the absence of a chemical shift reagent. Stejskal-
Tanner plots in this case appear biexponential, with the amplitude of the “slow” component 
corresponding to the sum of the intravesicular and intracubosomal population.  
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Conclusions  
Diffusion measurements can be used to study drug delivery systems. When chemical exchange 
between intra-vehicular and bulk-solution compartments is either slow or intermediate on the 
diffusion time scale, the relative sizes of the two populations can be determined from biexponential 
Stejskal-Tanner plots, without the need for chemical shift resolution. This is an advantage if the 
vehicles are accessible to a chemical shift reagent, or if its addition is undesirable. In the case of 
intermediate chemical exchange, the relative sizes of the two populations must be estimated by 
extrapolation to zero effective diffusion time (td) rather than from a single Stejskal-Tanner plot. The 
same applies to the case when relaxation rate constants of the two populations are different and their 
values are unknown. The relative time scale of chemical exchange in the diffusion experiment 
depends on the values of the diffusion coefficients involved, the relative population sizes, the rate 
constant k-, and can be modulated by the choice of the effective diffusion time td.  
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Figure Captions 
 
Figure 1. Equilibrium between free and bound drug in solution. Notation: A, free drug; B, vehicle-
bound drug; DDV, drug delivery vehicles (in this example, surfactant micelles). The drug is 
partitioned between the vehicles and extravehicular solution. The system is presumed to be in 
chemical equilibrium, and therefore for the purposes of Bloch equation analysis both k+ and k- are 
treated as first-order rate constants. NMR chemical shifts of free and bound drug are presumed to be 
unresolved; therefore, only the combined NMR signal of A and B is observed.  
 
 
 
Figure 2. Pulsed-field gradient spin echo pulse sequence (PGSE). In the rectangular-gradient pulse 
approximation, the effective diffusion time td = D - d/3. The first gradient pulse winds a 
magnetization grating of pitch 1/2pq, which is allowed to evolve until the 180o RF and the second 
gradient pulses refocus the magnetization. The diffusion coefficient(s) associated with the observed 
NMR signal can be measured by progressively increasing the strength of the PFGs (and thus the 
degree of diffusion attenuation of the grating) while keeping the time intervals constant.  
 
 29
Figure 3. Separability of the two components in a biexponential Stejskal-Tanner plot. The main 
features are as follows. The solid black line is a numerical biexponential fit of the experimental data 
points. The initial linear region corresponds to the average diffusion coefficient, and the terminal 
linear region, to the slow D. The hollow circle marks the critical point, bcrit, separating the two 
regimes (see Eq. [15]). The grey area around the fit (area D) is the region of flexibility of the fit. In 
order for the two components to be separable, the critical point needs to be separated from the fit 
line by several widths of the flexibility region, as is the case here. Regions A, B, and C are 
experimentally inaccessible due to large required g values, short required td values, and low 
sensitivity, respectively.  
 
 
Figure 4. The 1H NMR spectrum of a 9.15% (w/v) solution of Solutol HS15 in D2O-saline. The 
insets show the structures of the two principal components of Solutol HS15, poly(ethylene glycol) 
(PEO) and poly(ethylene glycol)(15) 12-hydroxystearate (PEO-HS ester).  
 
 
Figure 5. A Stejskal-Tanner plot for the PEO signal in the system shown in Fig. 4. The two 
observed diffusion coefficients (1.7 ´ 10-10 and 1.9 ´ 10-11 m2 s-1) correspond to free PEO and 
micellized PEO-HS ester. The respective population amplitudes are 63% and 37%.  
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Figure 6. Monoolein molecule, bilayer, and a cubosome. When dispersed in water under 
appropriate conditions, monoolein molecules self-assemble into a bilayer, which is in turn contorted 
into a periodic surface of cubic Im3m symmetry. Cubosomes are submicron-sized chunks of this 
structure stabilized against flocculation by a surfactant. Their channel system is bicontinuous, i.e., 
there are two congruent non-intersecting sets of channels. For hydrophilic species, the mechanism 
of entrapment probably is that they become “lost” in the tortuous channels, rather than being 
actively entrapped by the bilayer.  
 
 
 
Figure 7. A representative Stejskal-Tanner plot of 23Na+ diffusion attenuation in a cubosome 
dispersion containing 10% (w/v) monoolein and 1% (w/v) Poloxamer 407 dispersed in D2O-saline. 
The two observed diffusion coefficients correspond to Na+ ions in the free solution (fast) and inside 
vesicles and cubosome channels (slow). The apparent relative fraction of the slow population is of 
the order of 3% and depends on td according to Eq. [14].  
 
 
 
Figure 8. The diffusion-time dependence of the apparent xB measured from the Stejskal-Tanner 
plots. The xB(app) extrapolates at td = 0 to xB = 3.7%, the fraction of the “slow” Na+ population (this 
includes intravesicular and intracubosomal pool).  
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